ATHENAHEALTH INC 4
4 · ATHENAHEALTH INC · Filed May 16, 2017
Insider Transaction Report
Form 4
ATHENAHEALTH INCATHN
O'Brien Timothy John
SVP, Chief Marketing Officer
Transactions
- Sale
Common Stock
2017-05-12$107.02/sh−3,398$363,654→ 11,035 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 13, 2017, in accordance with Rule 10b5-1.
- [F2]Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.95 to $107.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote (2).
- [F3]The securities reported in this Column 5 are units of common stock granted pursuant to Restricted Stock Unit ("RSU") awards under the athenahealth, Inc. 2007 Stock Option and Incentive Plan, as amended and restated. The RSUs are subject to time-based vesting and will be settled only in stock.